Compounds for stem cell differentiation
Small molecule compounds and methods for stem cell differentiation are provided herein. An example of a class of compounds that may be used to practice the methods disclosed herein is represented by enantiomerically pure isomers of compounds of Formula I: or a chirally pure stereoisomer, pharmaceutically acceptable salt, or solvate thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 5′ , R 6 , R 6′ , R 7 , R 7′ are as described herein.
1. A compound selected from the group consisting of:
compounds having structural Formula (I):
chirally pure stereoisomers, and pharmaceutically acceptable salts and solvents thereof, wherein:
R 14 is selected from the group consisting of hydrogen, halogen, perhaloalkyl, alkyl, nitro, hydroxyl, alkoxyl, carboxyl and C 1 -C 6 alkyl,
R 15 is hydrogen, C 2 -C 6 alkyl, methyl prolinol, 4-ethyl piperidine, N-t-butyl carbamyl 4-ethyl piperidine, perhaloalkyl, trifluoroethyl, trifluoromethyl, benzyl, substituted benzyl, cycloalkyl or substituted cycloalkyl
R 16 is hydrogen, C 1 -C 6 alkyl, furyl or substituted furyl; and
one of R 17 and R 18 is hydrogen and the other is C 1 -C 6 alkyl;
and compounds having structural Formula (II):
and chirally pure stereoisomers, and pharmaceutically acceptable salts and solvates thereof, wherein:
R 19 is selected from the group consisting of hydrogen, phenyl, 3-(5-indoyl), 4-pyrazole, halogen, perhaloalkyl, alkyl, nitro, hydroxyl, alkoxyl, carboxyl and C 1 -C 6 alkyl, wherein phenyl, 3-(5-indoyl), and 4-pyrazole are each independently substituted with 1-3 R 23 ,
R 20 is hydrogen, C 2 -C 6 alkyl, methyl prolinol, 4-ethyl piperidine, N-t-butyl carbamyl 4-ethyl piperidine, perhaloalkyl, trifluoroethyl, trifluoromethyl, benzyl, substituted benzyl, cycloalkyl or substituted cycloalkyl, and
R 21 is hydrogen, C 1 -C 6 alkyl, furyl or substituted furyl;
R 22 is hydrogen; and
R 23 is selected from the group consisting of hydrogen, halogen, perhaloalkyl, alkyl, nitro., hydroxyl, alkoxyl, carboxyl and C 1 -C 6 alkyl.
2. A compound: selected from the group consisting of
3. The compound of claim 1 , wherein the pharmaceutically acceptable salt is the salt of 1-hydroxy-2-naphthoic acid, 2,2-dichloroacetic acid, 2-hydroxyethanesulfonic acid, 2-oxoglutaric acid, 4-acetamidobenzoic acid, 4-aminosalicylic acid, acetic acid, adipic acid, ascorbic acid (L), aspartic acid (L), benzenesulfonic acid, benzoic acid, camphoric acid (+), camphor-10-sulfonic acid (+), capric acid (decanoic acid), caproic acid (hexanoic acid), caprylic acid (octanoic acid), carbonic acid, cinnamic acid, citric acid, cyclamic acid, dodecylsulfuric acid, ethane-1,2-disulfonic acid, ethanesulfonic acid, formic acid, fumaric acid, galactaric acid, gentisic acid, glucoheptonic acid (D), gluconic acid (D), glucuronic acid (D), glutamic acid, glutaric acid, glycerophosphoric acid, glycolic acid, hippuric acid, hydrobromic acid, hydrochloric acid, isobutyric acid, lactic acid (DL), lactobionic acid, lauric acid, maleic acid, malic acid (−L), malonic acid, mandelic acid (DL), methanesulfonic acid, naphthalene-1,5-disulfonic acid, naphthalene-2-sulfonic acid, nicotinic acid, nitric acid, oleic acid, oxalic acid, palmitic acid, pamoic acid, phosphoric acid, proprionic acid, pyroglutamic acid (−L), salicylic acid, sebacic acid, stearic acid, succinic acid, sulfuric acid, tartaric acid (+L), thiocyanic acid, toluenesulfonic acid (p), or undecylenic acid.
4. The compound of claim 1 , wherein the compound has structural Formula (I).
5. The compound of claim 4 , wherein R 14 is hydrogen.
6. The compound of claim 4 , wherein R 15 is ethyl.
7. The compound of claim 4 , wherein R 16 is methyl.
8. The compound of claim 1 , wherein the compound has structural Formula (II).
9. The compound of claim 8 , wherein R 19 is phenyl.
10. The compound of claim 9 , wherein R 23 is perhaloalkyl.
11. The compound of claim 1 , wherein R 19 is hydrogen.
12. The compound of claim 11 , wherein R 23 is alkyl.